Bristol-Myers Squibb Company

Lawsuit Filings

Gilead, Bristol-Myers Squibb Facing Antitrust Class Action Over Alleged Anti-Competitive Grip on HIV Drug Market

October 13, 2020 A class action alleges Gilead Sciences and Bristol-Myers Squibb have for years conspired to restrain the U.S. market for HIV treatment drugs, allowing the companies to overcharge direct buyers.

Failed CheckMate-026 Lung Cancer Trial Comes Up in Securities Complaint Against Bristol-Myers Squibb

February 15, 2018 A class action lawsuit has been filed on behalf of anyone who acquired securities for Bristol-Myers Squibb Company between 1/27/15 and 10/9/16.